Modern Wealth Management LLC Buys New Stake in Axon Enterprise, Inc $AXON

Modern Wealth Management LLC bought a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,751 shares of the biotechnology company’s stock, valued at approximately $1,257,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. Newbridge Financial Services Group Inc. grew its stake in shares of Axon Enterprise by 2.8% in the second quarter. Newbridge Financial Services Group Inc. now owns 508 shares of the biotechnology company’s stock worth $421,000 after purchasing an additional 14 shares in the last quarter. Vicus Capital raised its stake in shares of Axon Enterprise by 3.7% during the third quarter. Vicus Capital now owns 396 shares of the biotechnology company’s stock valued at $284,000 after purchasing an additional 14 shares in the last quarter. Evergreen Capital Management LLC raised its stake in shares of Axon Enterprise by 3.8% during the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after purchasing an additional 15 shares in the last quarter. STF Management LP lifted its holdings in Axon Enterprise by 1.4% in the second quarter. STF Management LP now owns 1,164 shares of the biotechnology company’s stock worth $964,000 after purchasing an additional 16 shares during the period. Finally, Blue Trust Inc. lifted its holdings in Axon Enterprise by 2.5% in the third quarter. Blue Trust Inc. now owns 645 shares of the biotechnology company’s stock worth $463,000 after purchasing an additional 16 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $574.01 on Monday. Axon Enterprise, Inc has a 52 week low of $396.41 and a 52 week high of $885.91. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. The stock has a market cap of $46.15 billion, a PE ratio of 377.64, a price-to-earnings-growth ratio of 12.25 and a beta of 1.46. The company’s 50-day moving average price is $536.08 and its two-hundred day moving average price is $616.86.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.55. The company had revenue of $796.72 million during the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The business’s revenue for the quarter was up 38.5% on a year-over-year basis. During the same quarter last year, the firm posted $2.08 EPS. As a group, sell-side analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

AXON has been the subject of a number of recent analyst reports. Royal Bank Of Canada decreased their target price on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. Wall Street Zen raised shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Needham & Company LLC lowered their price objective on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a research note on Friday, February 20th. Finally, William Blair reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $762.93.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 revenue and bookings beat expectations — Axon reported quarterly revenue of ~$796.7M (up ~38.5% YoY) and said bookings were at record levels, driven by recurring software/services and AI products; investors are rewarding the growth narrative. Read More.
• Positive Sentiment: AI and acquisitions broaden the TAM — Axon is rolling out AI tools (Draft One) and expanding into emergency communications via buys like Carbyne and Prepared, pushing the company from hardware into a higher‑margin, recurring‑revenue public‑safety platform. Read More.
• Positive Sentiment: Hardware momentum in Connected Devices — demand for TASER 10, Axon Body 4 and counter‑drone solutions boosted device sales, helping current revenue strength and cross‑sell into Axon Cloud subscriptions. Read More.
• Neutral Sentiment: Street attention and bull narratives — multiple outlets and bullish newsletters have flagged Axon as a pick, increasing retail/institutional focus but also raising expectations. Read More.
• Negative Sentiment: Profitability collapsed despite revenue growth — quarterly net income plunged (reported near break‑even), compressing EPS and margins; that raises near‑term profitability and margin recovery questions. Read More.
• Negative Sentiment: Insider selling — Axon’s CAO sold 1,500 shares (~$860k), which may be viewed negatively by some investors even though the remaining insider stake remains material. Read More.
• Negative Sentiment: Analysts trimmed targets — some firms cut price targets (Morgan Stanley, Barclays) even as many maintain buy/overweight positions, signaling debate about valuation vs. execution. Read More.
• Negative Sentiment: High valuation and execution risk — AXON trades at a very high P/E, leaving the stock sensitive to execution on margin recovery, successful AI monetization and integration of acquisitions. Read More.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total value of $5,002,400.00. Following the transaction, the chief executive officer owned 3,090,997 shares in the company, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total value of $860,175.00. Following the completion of the transaction, the chief accounting officer directly owned 12,240 shares in the company, valued at $7,019,028. This represents a 10.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 26,634 shares of company stock valued at $14,963,095 in the last ninety days. Company insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.